$Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor$

PremiumPress Releases

Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor

23d ago

DAWN

PremiumCompany Announcements

A New Cause for Concern: Day One Biopharmaceuticals, Inc. Adds a New Regulation Risk

3M ago

DAWN

PremiumCompany Announcements

Day One Biopharmaceuticals Updates Corporate Presentation

3M ago

DAWN

More DAWN News >

DAWN News on the Web

2024-05-07

DAWN Stock Earnings: Day One Biopharmaceutical Misses EPS for Q1 2024

InvestorPlace

Neutral

2024-05-06

Day One Reports First Quarter 2024 Financial Results and Corporate Progress

Yahoo Finance

Neutral

2024-05-04

Insider Sale at Day One Biopharmaceuticals Inc

Yahoo Finance

Neutral

2024-05-01

FDA Approval Gives Day One Biopharmaceuticals (NASDAQ:DAWN) More Room to Run

TipRanks News

Bullish

2024-04-25

Day One comments from call weighing on sentiment, says BofA

The Fly

Neutral

2024-04-24

Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Day One Biopharmaceuticals (DAWN) and Roche Holding AG (OtherRHHVF)

TipRanks News

Bullish

2024-04-23

Day One should rally to $17.50-$18 on approval, says JonesResearch

The Fly

Neutral

2024-04-23

Day One’s OJEMDA™ , the Most Common Form of Childhood Brain Tumor

Yahoo Finance

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DAWN’s Media Buzz Sentiment?

Currently, no data Available

What is DAWN’s weekly average amount of articles?

Currently, no data Available

What is DAWN’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

MTDMettler-Toledo

ALCAlcon

CABACabaletta Bio

PYXSPyxis Oncology

BOLTBolt Biotherapeutics

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing